Lastly, our previous study [11] showed that NUDT15 variants may cause neutropenia, and that the 6-MP dosage should be considered in patients according to the NUDT15 variants to inform personalized 6-MP therapy in pediatric patients. The gene discussed is NUDT15; the disease is neutropenia.